GRETA MELTON: Open Payments
NPI 1144080805 · PANAMA CITY, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$565 in 21 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $0 · 2025 $565
Food & beverage: $565
| Company | Payments | Amount |
|---|---|---|
| SCPHARMACEUTICALS INC. | 5 | $104 |
| ABBVIE INC. | 1 | $97 |
| Vantive US Healthcare LLC | 1 | $78 |
| Fresenius USA Marketing, Inc. | 3 | $75 |
| Travere Therapeutics, Inc. | 3 | $74 |
| Bayer Healthcare Pharmaceuticals Inc. | 2 | $36 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Chiesi USA, Inc. | 1 | $20 |
| OPKO Pharmaceuticals, LLC | 1 | $19 |
| Otsuka America Pharmaceutical, Inc. | 1 | $16 |
Products named: FUROSCIX, VRAYLAR, Renal - PD, VELPHORO, Kerendia, FARXIGA, ELFABRIO, RAYALDEE.
Industry payments across FL — which companies pay providers there.
